US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.700
  • +0.060+3.66%
Close Jul 22 16:00 ET
  • 1.661
  • -0.039-2.31%
Post 18:46 ET
195.03MMarket Cap-2297P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
Operating revenue
137.58%77.06M
21.89%257.24M
101.81%91.52M
64.16%74.57M
-2.39%58.72M
-46.04%32.44M
-35.37%211.04M
-38.19%45.35M
-44.94%45.42M
-31.37%60.15M
Cost of revenue
104.97%34.59M
126.86%158.99M
495.46%84.57M
-7.18%32.7M
120.34%24.85M
80.09%16.87M
21.69%70.08M
17.33%14.2M
65.57%35.23M
-32.46%11.28M
Gross profit
172.95%42.48M
-30.30%98.25M
-77.67%6.96M
310.84%41.87M
-30.70%33.87M
-69.33%15.56M
-47.59%140.96M
-49.16%31.15M
-83.36%10.19M
-31.11%48.87M
Operating expense
2.03%85M
-24.23%301.45M
-8.21%75.86M
-18.50%73.87M
-26.35%68.41M
-36.73%83.31M
-25.33%397.84M
-18.02%82.64M
-3.59%90.64M
-2.34%92.89M
Selling and administrative expenses
15.01%56.53M
-3.26%192.02M
-7.70%49.49M
7.57%48.22M
-11.96%45.14M
0.82%49.15M
16.95%198.48M
7.13%53.62M
12.29%44.83M
27.09%51.28M
Research and development costs
-16.64%28.47M
-45.11%109.44M
-9.14%26.37M
-44.01%25.65M
-44.08%23.27M
-58.81%34.15M
-45.10%199.36M
-42.83%29.02M
-15.30%45.81M
-24.02%41.61M
Operating profit
37.23%-42.53M
20.90%-203.2M
-33.81%-68.91M
60.22%-32.01M
21.52%-34.54M
16.29%-67.75M
2.64%-256.88M
-30.21%-51.49M
-145.37%-80.45M
-82.14%-44.01M
Net non-operating interest income expense
-14.46%-11.12M
-24.84%-40.54M
-13.15%-10.62M
-36.18%-10.27M
-51.11%-9.94M
-8.28%-9.71M
-41.44%-32.47M
-62.01%-9.39M
-30.65%-7.54M
-14.49%-6.58M
Non-operating interest expense
14.46%11.12M
24.84%40.54M
13.15%10.62M
36.18%10.27M
51.11%9.94M
8.28%9.71M
41.44%32.47M
62.01%9.39M
30.65%7.54M
14.49%6.58M
Other net income (expense)
8,957.64%156.52M
327.88%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
127.92%1.73M
-748.06%-2.4M
621.56%2.01M
4,363.33%1.34M
3,927.27%443K
Special income (charges)
--153.65M
--0
--0
--0
--0
--0
---6.22M
--0
--0
--0
-Less:Other special charges
----
----
----
----
----
----
--6.22M
--0
----
----
-Gain on sale of business
--153.65M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
66.03%2.87M
43.09%5.47M
-106.42%-129K
68.26%2.25M
265.01%1.62M
5,300.00%1.73M
1,450.53%3.82M
621.56%2.01M
4,363.33%1.34M
3,927.27%443K
Income before tax
235.85%102.88M
18.33%-238.27M
-35.30%-79.65M
53.81%-40.02M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
Income tax
0
-380K
0
-380K
0
0
0
0
0
0
Net income
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
Net income continuous Operations
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
Minority interest income
Net income attributable to the parent company
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
-124.90%-86.65M
-67.73%-50.15M
Basic earnings per share
194.79%0.91
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
-62.50%-0.65
Diluted earnings per share
186.46%0.83
32.71%-2.53
6.58%-0.71
63.06%-0.41
24.62%-0.49
22.58%-0.96
1.31%-3.76
-26.67%-0.76
-126.53%-1.11
-62.50%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M-31.37%60.15M
Operating revenue 137.58%77.06M21.89%257.24M101.81%91.52M64.16%74.57M-2.39%58.72M-46.04%32.44M-35.37%211.04M-38.19%45.35M-44.94%45.42M-31.37%60.15M
Cost of revenue 104.97%34.59M126.86%158.99M495.46%84.57M-7.18%32.7M120.34%24.85M80.09%16.87M21.69%70.08M17.33%14.2M65.57%35.23M-32.46%11.28M
Gross profit 172.95%42.48M-30.30%98.25M-77.67%6.96M310.84%41.87M-30.70%33.87M-69.33%15.56M-47.59%140.96M-49.16%31.15M-83.36%10.19M-31.11%48.87M
Operating expense 2.03%85M-24.23%301.45M-8.21%75.86M-18.50%73.87M-26.35%68.41M-36.73%83.31M-25.33%397.84M-18.02%82.64M-3.59%90.64M-2.34%92.89M
Selling and administrative expenses 15.01%56.53M-3.26%192.02M-7.70%49.49M7.57%48.22M-11.96%45.14M0.82%49.15M16.95%198.48M7.13%53.62M12.29%44.83M27.09%51.28M
Research and development costs -16.64%28.47M-45.11%109.44M-9.14%26.37M-44.01%25.65M-44.08%23.27M-58.81%34.15M-45.10%199.36M-42.83%29.02M-15.30%45.81M-24.02%41.61M
Operating profit 37.23%-42.53M20.90%-203.2M-33.81%-68.91M60.22%-32.01M21.52%-34.54M16.29%-67.75M2.64%-256.88M-30.21%-51.49M-145.37%-80.45M-82.14%-44.01M
Net non-operating interest income expense -14.46%-11.12M-24.84%-40.54M-13.15%-10.62M-36.18%-10.27M-51.11%-9.94M-8.28%-9.71M-41.44%-32.47M-62.01%-9.39M-30.65%-7.54M-14.49%-6.58M
Non-operating interest expense 14.46%11.12M24.84%40.54M13.15%10.62M36.18%10.27M51.11%9.94M8.28%9.71M41.44%32.47M62.01%9.39M30.65%7.54M14.49%6.58M
Other net income (expense) 8,957.64%156.52M327.88%5.47M-106.42%-129K68.26%2.25M265.01%1.62M127.92%1.73M-748.06%-2.4M621.56%2.01M4,363.33%1.34M3,927.27%443K
Special income (charges) --153.65M--0--0--0--0--0---6.22M--0--0--0
-Less:Other special charges --------------------------6.22M--0--------
-Gain on sale of business --153.65M------------------0----------------
Other non- operating income (expenses) 66.03%2.87M43.09%5.47M-106.42%-129K68.26%2.25M265.01%1.62M5,300.00%1.73M1,450.53%3.82M621.56%2.01M4,363.33%1.34M3,927.27%443K
Income before tax 235.85%102.88M18.33%-238.27M-35.30%-79.65M53.81%-40.02M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M
Income tax 0-380K0-380K000000
Net income 235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M
Net income continuous Operations 235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M
Minority interest income
Net income attributable to the parent company 235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M-124.90%-86.65M-67.73%-50.15M
Basic earnings per share 194.79%0.9132.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11-62.50%-0.65
Diluted earnings per share 186.46%0.8332.71%-2.536.58%-0.7163.06%-0.4124.62%-0.4922.58%-0.961.31%-3.76-26.67%-0.76-126.53%-1.11-62.50%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg